CAS RN: 153851-71-9

BIAPENEM SIDE CHAIN

Product Availability

Choose a grade to view its available package options.

2 package records1 with current stock2 grade groups
Batch No.PackageAvailabilityWarehouseLead TimeInquiry
Batchno.20260116 250mg / 1g / 5g Confirm by inquiry Shanghai, Shandong Inquiry
Batch No.PackageAvailabilityWarehouseLead TimeInquiry
Batchno.20250810 1g / 5g Out of stock 8-10 business days Inquiry
  • Product code: SSC-063225
GET A QUOTE
Historical Factory Record

Historical Supply Reference

This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.

  • Pack sizes on record: 5g
  • Available purity: >95%
  • Inventory rows with stock: 0
  • Bulk packaging: confirmed by inquiry
Request Bulk Quote

Reference Pack Sizes

Reference pack sizes are shown below. Final availability, packaging and delivery schedule are confirmed by inquiry.

Recorded sizes, purity and stock details for CAS 153851-71-9
Pack Size Recorded Purity Available Qty Ship From Inquiry
5g >95% 0 Out of Stock Shanghai Inquiry

153851-71-9 / 6,7-dihydro-5H-pyrazolo[1,2-a][1,2,4]triazol-4-ium-6-thiol chloride

Standard CAS: 153851-71-9 Multi CAS: No

Basic Information

CAS
153851-71-9
Multi CAS
No
Molecular Formula
C5H8ClN3S
Molecular Weight
177.660000
Exact Mass
177.012746
SMILES
C1C(C[N+]2=CN=CN21)S.[Cl-]
InChI
InChI=1S/C5H7N3S.ClH/c9-5-1-7-3-6-4-8(7)2-5;/h3-5H,1-2H2;1H
InChIKey
HPBXUFOSZBCEIQ-UHFFFAOYSA-N

Computed Properties

Structural Parameters

Heavy atom count
10
Aromatic heavy atom count
5
Fraction Csp3
0.6
H-bond acceptors
3
H-bond donors
1
Molar refractivity
35.2
TPSA
21.7

LogP / Solubility

WLOGP
-3.51
MLOGP
-3.09
XLogP3
-3.51
Consensus LogP
-3.37
Log S (ESOL)
0.9
Class (ESOL)
Highly soluble
Log S (Ali)
1.52
Class (Ali)
Highly soluble
Log S (SILICOS-IT)
2.1
Class (SILICOS-IT)
Highly soluble

ADME

GI absorption
Low
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-6.3

Drug-likeness / Medicinal Chemistry

Lipinski
Yes
Ghose
No
Veber
Yes
Egan
Yes
Muegge
No
Bioavailability score
0.55
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
1.5

Safety & Transport

GHS Hazard Statements
Not Classified Reported as not meeting GHS hazard criteria by 1 of 1 companies. For more detailed information, please visit ECHA C&L website.

Get In Touch

Contact Us